Background: Pseudomonas aeruginosa is one of the major etiologic agents of nosocomial infection among burn patients that has high resistance to antibiotics. Integrons can extend antibiotic resistance genes among bacteria. The aim of this study was to investigate the antibiotic resistance pattern and the prevalence of integron among P. aeruginosa isolates.

Materials and Methods: In this cross-sectional study, a total of 73 P. aeruginosa isolated from burn wound infections among hospitalized patients in Ahvaz Taleghani hospital. Antibiotic resistance pattern of these bacteria was investigated to 9 antibiotics by Disk Agar Diffusion method. Polymerase chain reaction (PCR) method was used to investigate the prevalence of class 1, 2 and 3 integrons. The data were analyzed by Chi-square test. A P-value of <0.05 was considered as a statistical significance level.

Results: The most antibiotic resistance level was seen against ofloxacin (94.5%), aztreonam (94.5%), and ceftazidime (93.6%). Fifteen isolates of P. aeruginosa were resistance to all of the antibiotics. The study of molecular results showed that class 1 integron was detected in 35.6% of isolates, while none of them harbored class 2 and 3 integron.

Conclusion: The rates of antibiotic resistance in pseudomonas aeruginosa to antibiotics such as ceftazidime, oflaxacin, aztreonam, cefepime, and ceftriaxone is very high. Although, class 1 integron were detected in 35.6% of isolates, there was no statistically significant differences between the presence of integron and resistance to a specific antibiotic, that it shows the role of the other antibiotic resistance mechanisms among pseudomonas aeruginosa.

Background: Gentamicin is an aminoglycoside antibiotic that broadly is used to treat gram negative bacteria infections, although it has side effects such as nephrotoxicity. According to antioxidant, anti-inflammatory and vasodilatory properties of Zataria Multiflora, the effects of co-treatment with zataria Multiflora and hydroalcholic extract on gentamicin induced nephrotoxicitj were investigated.

Materials and Methods: In this study, male rats of Vistar race were divided into 4 groups: control group, co-treatment with gentamicin and vehicle group, co-treatment with gentamicin and zataria Multifiora extract group, and co-treatment with zataria Multiflora extract and normal saline solution group. Zataria Multiflora hydroalcoholic extract was added to drinking water as 800 PPm concentration. They, systolic blood pressure and renal blood flow (RBF) were measured. Also, the amounts of urea, creatinine, sodium, potassium and osmolarity were measured in plasma and urine samples

 Results: In co-treatment group with zataria Multiflora extract, the amounts of urea, creatinine, absolute sodium excretion and relative sodium and potassium excretion and malondialdehyde (MDA) that have been inceased in treatment with gentamicin, significantly were reduced. Creatinine clearance, urine osmolarity, RBF and FRAP that was decreased in gentamicin group in compare to control group, significantly increased.

Conclusion: Co-treatment prevents nephrotoxicity induced by gentamicin and attenuates oxidative-stress associated renal injury by reducing oxygen free radicals and lipid peroxidation, So it can be effective to cure rats receiving gentamicin.

Background: Gentamicin (GM) is one the aminoglycoside antibiotics which isroutinelyused to treatinfections gram-negative, either alone or insynergistic withbeta-lactamantibioticsused. However, frequent useleads toserious side effectssuch asrenal toxicity, ototoxicity. Coenzyme Q₁₀ has antioxidant, anti-inflammatory and vasodilatory properties. According to these properties of Coenzyme Q₁₀ and tissue damage mechanism in GM induced-nephrotoxicity, in this study, the effects of these two substances for the co-treatment and post -treatment on renal injury induced by gentamicin were investigated.

Materials and Methods:  Experiments has been done on 77 male Wistar rats in weight range of 200 to 250 g. Animals were divided randomly into 5 groups of 7 numbers. Renal nephrotoxicity induced by i.p injection of gentamicin (100mg/kg) Therapeutic effect of coenzyme Q₁₀ (10mg/kg)in the two protocols co-treatment  and post-treatmentwas investigated.The animals after the last injectionon the ninth day of co-treatment andthe seventeenth day of post-treatmentwere placed into individual metabolic cages so as to collection urine and urine volume was measured gravimetrically. Afteranesthesia, systolic blood pressure and renal blood flow was measured. Then blood sampling was done. Amount of urea, creatinin, sodium, potassium and osmolarity was measured in plasma and urine samples. Left kidney, for doing histological experiments in 10% buffered formaldehyde and right kidney for biochemical experiments in fluid nitrogen was preserved.

Results: Co-treatment with Coenzyme Q10 significantly decreased fractional excretion of sodium (6.37±1.33 %; p<0.001) and decreased fractional excretion of potassium(219.14±83.8 %; p<0.001) MDA levels (2.13 ±0.24µmol/gkw; p<0.001), and significantly increased renal blood flow (6.38 ±0.1ml/min: p<0.01) and FRAP levels (24.44±0.42mmol/gkw; p<0.001). Post-treatment with coenzyme Q10 significantly decreased fractional excretion of sodium (3.58 ±0.57 %; p<0.001), potassium (111.77±29.4%; p<0.001) and MDA levels (3.08 ±0.12µmol/gkw; p<0.001) and significantly increased renal blood flow (6.74±0.15ml/min: p<0.001) and FRAP levels (24.34±0.75mmol/gkw; p<0.001) that is reduced by gentamicin.

Conclusion: According to the results, this study showed thatpost- treatment with coenzyme Q₁₀more protective effect on the kidney tissue andAnda greater increase inantioxidant defensecreated.